Addressing residual risk beyond statin therapy: New targets in the management of dyslipidaemias–A report from the European Society of Cardiology Cardiovascular Round Table

1. Mach, F.
2. Visseren, F.L.J.
3. Cater, N.B.
4. Salhi, N.
5. Soronen, J.
6. Ray, K.K.
7. Delgado, V.
8. Jukema, J.W.
9. Laufs, U.
10. Zamorano, J.-L.
11. Ros, E.
12. Plat, J.
13. Gesztes, A.G.
14. Tokgozoglu, L.
15. Packard, C.
16. Libby, P.